Sumatriptan Succinate
Product Images NDC 52959-510

4 FDA label images from H.j. Harkins Company, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sumatriptan Succinate (NDC 52959-510). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H.j. Harkins Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Fig1)

Fig1 (Fig1)
A line graph depicting the estimated probability of response over time in minutes from the first dose. Four curves represent placebo, 25 mg, 50 mg, and 100 mg doses of Sumatriptan Succinate, showing increasing response probabilities with higher doses over a 240-minute period.*
FDA Label Image

Fig2 (Fig2)

Fig2 (Fig2)
A line graph comparing the estimated probability of renal injury or reuse over 24 hours after an initial dose. Four groups are shown: placebo, 25 mg, 50 mg, and 100 mg dosages of an unspecified treatment. The graph shows increasing probabilities over time, with higher doses associated with higher probabilities.*
FDA Label Image

Sumatriptan Succ. 100mg Tablet (Label)

Sumatriptan Succ. 100mg Tablet (Label)
Sumatriptan Succinate 100 mg tablet packaging label showing product name, strength, and dosage form. Label includes lot number STS100YR, manufacturer Dr. Reddy's, expiration date 12/11, and comparison to brand name Imitrex with corresponding NDC 55111-293-09. Tablets are white round pills made in India. Packaging also includes patient directions and cautionary statements, with several identical smaller labels listing quantity as 9 tablets per package. Labeler is H.J. Harkins Company, Inc.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Sumatriptan Succinate, showing the molecular arrangement of its active ingredient components as depicted in the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.